Macro Dragon: China’s back, Coronavirus, “The Bern" Macro Dragon: China’s back, Coronavirus, “The Bern" Macro Dragon: China’s back, Coronavirus, “The Bern"

Macro Dragon: China’s back, Coronavirus, “The Bern"

Macro 4 minutes to read
Kay Van-Petersen

Global Macro Strategist

Summary:  Welcome to WK 6, we start of with welcoming China mkts back with what so far seems to be a much better than expected Mon open. Latest data points from the virus as of this Mon morning, the official figures are at c. 17,300 confirmed cases, +360 deaths & c. 500 recovered.

We have also gotten one death out of China in the PH, which was of an individual from Wuhan - can you imagine if that death was in the US.

Key risk over next 24-48hrs is not the Coronavirus but "The Bern", watch out for the Iowa Caucuses tonight US Mon evening. Bernie equals Very Bad For US EQ. Sleepy Joe equals Good for US EQ

Rest of the wk is action packed we have ISMS (key US mfg. ISM tonight, PMIs, NFP & a host of central bank meetings from: Australia, Thailand, Brazil, Philippines, India & Russia. We also should finally have an end to the democratic tax-funded complete waste of resources & bandwidth that is the impeachment of Trump.

(These are solely the views & opinions of KVP, & do not constitute any trade or investment recommendations. By the time you synthesize this, things may have changed.)



Macro Dragon: China’s back, Coronavirus, “The Bern"


2019-nCoV Update Mon Asia Mrn 3 Feb…

  • We’ve expanded our thoughts this wk with a combination of updates, potential scenarios around opportunities & risk surrounding the Novel Coronavirus (a.k.a. 2019-nCoV / Wuhan Coronavirus) here on Fri 31 Jan, here on Thu 30 Jan, here on Wed 29 Jan & here on Tue 28 Jan.
  • Whilst overall KVP retains his bearish tactical skew - despite what seems to be a much more constructive open this Asia Mon Morning than he was expecting - there is no doubt work to be done for the buying opportunity that will come… when that is… again remains hard to say… as there will be a bounce purely based on technicals & mean reversion (So more tactical)… yet the bounce on fundamentals (so more strategic) could definitely be harder – some areas such as Macau gaming & other aspects of tourism are going to take months, perhaps quarter or even +1yr to get back to previous levels, even once the virus is nipped in the bud (still seem a long way from that). Also the travel bans are still on the upswing & while those can be reversed in due course, psychologically, sapiens are super tribal – even amongst their own fellow countryfolk
  • China has injected a lot of liquidity to kick of the wk with over USD 170bn, that is no doubt lending a calming hand to things this morning… & as we wrap up today’s Macro Dragon US EQ futs are now up +0.70% to +0.8%... emnis at 3247… Hang Send is +0.45% to 26400ish.. & the A50 China Futures listed in SG are +0.76% to 12930, Shanghai Equites are down c. -7% at 3725, gold -0.4% 1583, Silver -0.8% 17.90. Weather too many people were bearish or/and the plunge protection team are out in full force remains to be seen. What’s interesting is on the flips side we have USDCNH going above 7 again, which does not correlate with the rest of the better than expected price action. As we like to say as a form of patience & humility, early days.
  • Again as we’ve said a number of times on Macro Monday, don’t mistake intraday or even bullish complete sessions in Asia for the risk of the virus being over – we still have about half a wk to one wk to go on our max tactical bearishness based on everything we know now & likely still need to see a few trading sessions out of China. Key risk here is KVP is vastly underestimating how effect the response & measures on the ground have been, as well as the markets propensity to buy the dip – even in Asia which will be hardest hit from this deflationary spiral.   

Quick update & thoughts on the Virus since the Fri check in:

  • Most provinces in China have wisely extended the lunar new year holiday to next wkd – this should ideally take them/us out of the danger zone of the 2wks incubation period & lower the risk of carriers returning back to work & where they live as they crisscross a country of +1.4bn, close to 5x the size of the US’s population.
  • The travel restrictions globally are on the rise – be it governments outright barring Chinese citizens, or people who have been in Hubei province over the last 2wks or airlines closing down routes. This trend is still set to continue, from a strategists-traders perspective – its amazing to see how slow some governments & people are to appreciating just how severe things could become. Also politically there is no upside from having the virus cross into your borders & seeming incompetent for it
  • We have gotten our first death out of China, in the Philippines – which seems linked to a Chinese national who came from Wuhan. Obviously a death in the US, would be take a lot more seriously by the financial markets.
  • As of this Mon morning, the “official figures” are at c. 17,300 confirmed cases, +360 deaths & c. 500 recovered. KVP reckons closer conservative number of infected is likely +25,000 to 50,000 on the mainland… & before its all over we are likely going to be in the 6 figures… yet efforts on the ground definitely having a positive impact…
  • Out of China the countries with confirmed cases over 10 are: Japan 20, Thailand 19, Singapore 18, Hong Kong 15 (still amazing to KVP only 15 in HK), South Korea (15), Australia 10, Germany 10, Taiwan 10.
  • Its worth noting there also seems to be another outbreak in China, that is linked to poultry… a bird flu… which IF it becomes transmittable to humans (probability is not zero, yet nor is it high)… is way deadlier… Main point is it seems China is just getting everything thrown at it. When it rains, it pours. Yet countries are like human beings, generally speaking the biggest growth & breakthroughs come through adversity & challenges. KVP would not be surprised if there are a lot of long-term structural benefits from all this – Wuhan & Hubei changing from being synonymous with Industrial China to being cutting edge on Healthcare & Biotech (i.e. where weaknesses become strengths). At some point we will get structural big policy stimulus response, maybe even announced this or next wk or in sequence – would expect usual suspects of infrastructure, yet think this Coronavirus is going to be the best thing to have happened to the Chinese health care & medical system – which net-net, should end up benefiting its people tremendously
  • Also look for names like Tencent (Gaming) & other digital, delivery, non-face-face companies that could benefit from a less extrovert period of societal activities. Think streaming, Baba, Baidu, etc..


…”Moto Moto… so nice, you had to say it twice”…

This is a replay segment from Fri’s Macro Dragon – again due to its importance, key part to bear in mind here is what time-horizon are you playing & do your horizons/views match your exposure


…A few other Key Things This WK…

  • Key economic data – with US ISMs, AHE & NFPs being super key. These Data points are pivotal enough to potential disconnect the US Equity market focus away from the Coronavirus in the near-term. Note we got US ISM Mfg. figures due later today & Non-Mfg on Weds.
  • This also means we get final PMIs across the board globally.
  • We have China Caixin & trade date this wk – bottom line though, any data coming out of China at the moment is a complete wash & waste of time. I.e. there are big cuts on estimates in the works – even post markets eventually rallying, the deflationary shock of the 2019-nCov Virus could stay with us for months… in some areas (tourism) maybe quarters or up to a year plus
  • RBA Tues – market currently increased prob of a cut to just under 25%, which could take the rate to 0.50% (0.750%). We also have rate decisions out of Thailand (who we know want a weaker Thai Baht), Brazil (dovish skew & mkt expect 25bp cut to 4.25%), India & the Philippines – again dovish skew, yet in this case only cut expected on BSP’s side to 3.75% (4.00%). Russia also is expected to cut rates by 25bp to 6.00%. Note there is likely not going to be one major central bank that will not at some point comment on watching the effect of the virus, i.e. deflationary impact to China => EM Asia = > RoW… it’s a good excuse for them to keep things accommodative.  
  • Likely end of the Democratic Tax-Paid & Wasted Impeachment fiasco, where we have learnt nothing new & only lost time, money & patience with the bi-polarization that is clearly In US politics. Solution here is easy, just don’t pay congress… they’ll learn to work together real quick . Incentives drive everything & right now the wrong incentives (basically free remit to still get paid, yet without doing their job of making America better for its people) are for them to keep digging their heels deeper. The disconnect between US politics (& granted a lot of places globally, Australia’s Scott Morrison comes to mind) & its people is colossal – one could say its almost like they are living on different planets… & they are for all intents & purposes  
  • Continued focus on the Novel Coronavirus, 2019-nCoV, with Chinese Markets being back open from today Mon 3 Feb – despite quite a lot of provinces smartly (& As we suggested on Macro Dragon early last wk) extending the lunar holidays to Feb 9-13, taking us over to another wkd. Center of the storm & limited upside will continue to be Asia… at some points it’s a buy that extends beyond intraday bullish squeezes… yet KVP does not feel we are there yet. Yet chance favors the prepared mind, so do get out your radar list & playbook for when things start to change on a more structural basis…
  • Biggest risk to US equities & hence global equities, is actually likely not the coronavirus but a Bernie Sanders win tonight in the US Iowa Caucuses. The results should be out Asia Tues morning between 10:00 to Noon SGT/HKT/CST. A Biden victory on the other hand would be greeted very positively by US equities.


Have a fantastic wk ahead everyone, good luck on the month start, stay healthy as well as keep your mind open to profitable & abundant opportunities. Life happens for us.




Some Anchor Pieces from #SaxoStrats:

Quarterly Outlook 2024 Q3

Sandcastle economics

01 / 07

  • Macro: Sandcastle economics

    Invest wisely in Q3 2024: Discover SaxoStrats' insights on navigating a stable yet fragile global economy.

    Read article
  • Bonds: What to do until inflation stabilises

    Discover strategies for managing bonds as US and European yields remain rangebound due to uncertain inflation and evolving monetary policies.

    Read article
  • Equities: Are we blowing bubbles again

    Explore key trends and opportunities in European equities and electrification theme as market dynamics echo 2021's rally.

    Read article
  • FX: Risk-on currencies to surge against havens

    Explore the outlook for USD, AUD, NZD, and EM carry trades as risk-on currencies are set to outperform in Q3 2024.

    Read article
  • Commodities: Energy and grains in focus as metals pause

    Energy and grains to shine as metals pause. Discover key trends and market drivers for commodities in Q3 2024.

    Read article
  • The rise of populism: Far-right parties will influence the future

    The disheartening cycle of unresolved geopolitical conflicts, the rise of polarizing political parties, and the stagnation of productivity.

    Read article
  • Investing in China: Navigating Q1 amid economic challenges

    Understand China's political landscape in Q4 2023 and the impact on counter-cyclical initiatives, with a focus on the pivotal Q1 2024.

    Read article

The Saxo Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website is not intended to and does not change or expand on this. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:
- Notification on Non-Independent Investment Research (
- Full disclaimer (

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments. Saxo does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo or its affiliates.

Saxo Capital Markets HK Limited
19th Floor
Shanghai Commercial Bank Tower
12 Queen’s Road Central
Hong Kong

Contact Saxo

Select region

Hong Kong S.A.R
Hong Kong S.A.R

Saxo Capital Markets HK Limited (“Saxo”) is a company authorised and regulated by the Securities and Futures Commission of Hong Kong. Saxo holds a Type 1 Regulated Activity (Dealing in Securities); Type 2 Regulated Activity (Dealing in Futures Contract); Type 3 Regulated Activity (Leveraged Foreign Exchange Trading); Type 4 Regulated Activity (Advising on Securities) and Type 9 Regulated Activity (Asset Management) licenses (CE No. AVD061). Registered address: 19th Floor, Shanghai Commercial Bank Tower, 12 Queen’s Road Central, Hong Kong.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products may result in your losses exceeding your initial deposits. Saxo does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo does not take into account an individual’s needs, objectives or financial situation. Please click here to view the relevant risk disclosure statements.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit

The information or the products and services referred to on this site may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and services offered on this website are not directed at, or intended for distribution to or use by, any person or entity residing in the United States and Japan. Please click here to view our full disclaimer.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc. Android is a trademark of Google Inc.